1. Japan Stocks

  2. •

    Basic Materials

  3. •

    Chemicals - Specialty
DKS Co. Ltd.

DKS Co. Ltd.

4461.T
DKS Co. Ltd.JP flagTokyo Stock Exchange
10,840.00
JPY
-20.00
- -
115.02BMarket Cap
DKS Co. Ltd.
4461.T
(Tokyo Stock Exchange)

Recent

price

10,840.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
6,513.47
6,590.75
6,074.59
6,398.98
6,035.02
4,998.11
4,974.87
5,612.44
5,864.74
6,044.65
5,813.43
6,155.78
6,683.58
6,598.16
7,651.45
- -
6,604.37
Revenue per Share
146.91
19.36
93.39
156.54
193.43
208.14
236.97
330.21
254.09
198.09
251.94
244.77
-41.8
122.73
270
- -
122.84
Basic EPS, GAAP
242.69
82.07
-107.1
172.94
-78.48
-343.93
-14.28
247.54
-46.37
-174.29
54.75
280.82
-216.69
479.72
562.77
- -
- -
Free Cash Flow per Basic Share
24.82
34.83
32.81
32.46
32.35
44.88
50.08
59.72
69.8
104.95
69.99
69.93
86.26
59.9
89.93
- -
- -
Dividend per Share
1,493.97
1,361.58
1,419.08
1,540.63
1,792.26
1,726.64
1,075.82
2,260.35
2,444.28
2,535.36
2,715.82
2,887.04
2,890.39
3,005.02
3,182.58
- -
3,007.85
Book Value per Share
2,065.98
1,926.78
2,077.12
2,276.91
2,762.36
2,480.68
2,633.1
3,111.94
3,173.95
3,258.98
3,594.71
3,905.71
3,897.74
4,286.54
4,622.21
- -
4,290.57
Tangible Book Value per Share
8
9
9
9
9
11
11
10
10
10
10
10
10
10
10
- -
10
Basic Weighted Avg Shares
51,245
56,249
51,843
54,614
55,597
52,782
52,254
56,955
59,574
61,456
59,140
62,672
65,081
63,118
73,255
82,886
63,118
Sales/Revenue/Turnover
5.33
3.62
3.39
4.54
5.3
6.52
7.55
8.87
7.29
6.76
7.59
7.38
1.83
3.29
7.31
12.2
3.29
Operating Margin (%)
1,846
2,269
2,021
2,088
2,154
2,087
2,335
2,473
2,665
2,920
3,459
3,580
3,508
3,216
3,223
3,221
- -
Depreciation Expense
1,156
165
797
1,336
1,782
2,198
2,489
3,351
2,581
2,014
2,563
2,492
-407
1,174
2,585
6,169
1,174
Net Income, GAAP
37.2
72.06
38.28
36.24
30.04
29.5
25.77
27.16
29.35
30.11
26.87
27.26
122.32
29.88
26.43
26.2
29.88
Effective Tax Rate (%)
2.26
0.29
1.54
2.45
3.21
4.16
4.76
5.88
4.33
3.28
4.33
3.98
-0.63
1.86
3.53
7.44
1.86
Profit Margin (%)
2,503
3,647
4,891
7,931
15,198
11,707
15,400
17,875
15,141
18,951
21,926
24,808
24,772
28,455
30,715
29,820
28,455
Working Capital
6,793
7,877
9,610
10,868
14,979
15,959
19,412
18,240
17,359
23,201
24,809
23,602
25,479
26,773
24,526
14,674
26,773
LT Debt
16,498
16,949
18,200
19,886
26,156
26,745
28,044
31,958
33,589
34,264
37,402
40,382
38,295
41,295
44,503
58,256
41,295
Total Equity
5.26
1.65
2.91
3.88
4.5
4.79
5.51
6.58
5.28
4.67
4.83
4.74
-0.37
1.97
5.12
8.95
1.97
Return on Invested Capital (%)
4.42
0.58
2.81
4.1
4.86
5.82
6.21
6.54
4.94
3.3
4.2
3.34
-1.27
1.37
2.27
7.58
1.37
Return on Capital (%)
10.48
1.41
6.72
10.58
12.02
12.65
16.86
19.57
10.81
7.96
9.6
8.74
-1.41
4.13
8.73
18.71
4.13
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'24
Dec'24
Mar'24
ST Debt
8,157
8,388
8,363
LT Borrowings
27,913
26,461
24,950
LT Finance Leases
1,936
1,823
1,823
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
10
10
10
Market Capitalization
16,629
18,741
35,074

Working Capital

FRC

•

in mil. unless spec.
Sep'24
Dec'24
Mar'24
Total Current Assets
50,426
52,870
53,614
Cash, Cash Equivalents & STI
15,259
15,078
16,126
Accounts Receivable, Net
15,172
17,414
18,298
Inventories
15,010
14,566
14,140
Total Current Liabilities
22,009
24,138
25,159
Payables & Accruals
- -
- -
- -
ST Debt
8,157
8,388
8,363
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.44%
9.86%
30.9%
Free Cash Flow
-188.74%
-8.58%
17.67%
Net Income, GAAP
-21.85%
-49.74%
138.65%
Sales/Revenue/Turnover
4.8%
7.2%
13.15%
Total Cash Common Dividend
- -
- -
34.84%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
13,884
15,316
16,434
17,484
63,118
2025
- -
- -
- -
- -
73,255
2026
- -
- -
- -
- -
82,886

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-49.91
- -
- -
- -
122.73
2025
- -
- -
- -
- -
270
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
59.9
2025
- -
- -
- -
- -
89.93
2026
- -
- -
- -
- -
- -
Similar Companies
Kansai Nerolac Paints Limited (KANSAINER.NS)
Omkar Speciality Chemicals Limited (OMKARCHEM.NS)
Kraton Corporation (KRA)
International Zeolite Corp. (IZCFF)
Toda Kogyo Corp. (4100.T)
T. Hasegawa Co., Ltd. (4958.T)
Business
DKS Co. Ltd. is a Japan-based company primarily engaged in the production and sale of surfactants, other industrial chemicals, and life sciences-related products. Its business operations are divided into five key segments: surfactants (including nonionic, anionic, cationic, and amphoteric surfactants); amenity materials (such as sucrose fatty acid esters, cellulose-based polymer materials, vinyl-based polymer materials, and health supplements); urethane materials (polyether polyols, urethane prepolymers, and urethane systems); functional materials (materials for photocurable resins, aqueous urethane resins, flame retardants, and amide-based lubricants); and electronic device materials (conductive pastes for electronic components and pellets for injection molding). The company serves a broad range of industrial fields and markets its products both domestically and internationally. Founded in August 1918, DKS Co. Ltd. is headquartered in Kyoto, Japan. In recent developments, DKS Co. Ltd. has shown a strong financial turnaround in 2024, with net sales increasing by 21.3% to approximately ¥35.4 billion and a significant operating income improvement to ¥2.47 billion in the first half of the year. The company’s equity ratio improved to 40.7%, reflecting a stronger financial foundation. Additionally, DKS is advancing its research and product offerings through joint research projects, including a notable collaboration with D. Western Therapeutics Institute, Inc. aimed at developing new solutions in the life sciences sector. These efforts underline strategic growth in both industrial chemicals and life sciences-related products. The company also continues to invest heavily in upgrading facilities and production capacity to support its growth plans under its mid-term strategy "FELIZ 115," targeting sales expansion to ¥100 billion within the coming years. DKS Co. Ltd. operates globally with a focus on the industrial chemicals, functional materials, and life sciences markets and maintains a diversified product portfolio tailored for B2B clients across various industries. The company employs over 1,100 people on a consolidated basis and continues to leverage a strong base of product development, manufacturing expertise, and strategic partnerships to sustain its market competitiveness and growth trajectory. This description reflects the company’s comprehensive product lines, recent financial and strategic developments, and its established history and global operations as a chemical and materials manufacturer headquartered in Kyoto, Japan. All information is current as of late 2025.